{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:58Z","timestamp":1786980358686,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SVKM's NMIMS Deemed to be University","award":["IO403061"],"award-info":[{"award-number":["IO403061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02661-0","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T11:02:38Z","timestamp":1770634958000},"page":"687-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metformin exhibits gender specific impact on telomere dynamics by enhancing RAP1 expression in type-2 diabetes mellitus"],"prefix":"10.1007","volume":"63","author":[{"given":"Meghna","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrey","family":"Madeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-0261","authenticated-orcid":false,"given":"Ekta","family":"Khattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"1","key":"2661_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/epirev\/mxs008","volume":"35","author":"JL Sanders","year":"2013","unstructured":"Sanders JL, Newman AB (2013) Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev 35(1):112\u2013131","journal-title":"Epidemiol Rev"},{"key":"2661_CR2","doi-asserted-by":"publisher","first-page":"105261","DOI":"10.1016\/j.neubiorev.2023.105261","volume":"152","author":"SE Wolf","year":"2023","unstructured":"Wolf SE, Shalev I (2023) The shelterin protein expansion of telomere dynamics: linking early life adversity, life history, and the hallmarks of aging. Neurosci Biobehav Rev 152:105261","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"2661_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cell.2020.12.028","volume":"184","author":"D Chakravarti","year":"2021","unstructured":"Chakravarti D, LaBella KA, DePinho RA (2021) Telomeres: history, health, and hallmarks of aging. Cell 184(2):306\u2013322","journal-title":"Cell"},{"issue":"11","key":"2661_CR4","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1101\/gad.187211.112","volume":"26","author":"TT Chow","year":"2012","unstructured":"Chow TT et al (2012) Early and late steps in telomere overhang processing in normal human cells: the position of the final RNA primer drives telomere shortening. Genes Dev 26(11):1167\u20131178","journal-title":"Genes Dev"},{"key":"2661_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mad.2018.03.013","volume":"177","author":"RP Barnes","year":"2019","unstructured":"Barnes RP, Fouquerel E, Opresko PL (2019) The impact of oxidative DNA damage and stress on telomere homeostasis. Mech Ageing Dev 177:37\u201345","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"2661_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40169-016-0089-2","volume":"5","author":"Y Zhou","year":"2016","unstructured":"Zhou Y et al (2016) Shortened leukocyte telomere length in type 2 diabetes mellitus: genetic polymorphisms in mitochondrial uncoupling proteins and telomeric pathways. Clin Transl Med 5(1):8","journal-title":"Clin Transl Med"},{"issue":"1","key":"2661_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2009.09.070","volume":"209","author":"KD Salpea","year":"2010","unstructured":"Salpea KD et al (2010) Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 209(1):42\u201350","journal-title":"Atherosclerosis"},{"key":"2661_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/life15060873","author":"S Baliou","year":"2025","unstructured":"Baliou S et al (2025) The interplay between obesity and type 2 diabetes: common pathophysiological mechanisms contributing to telomere shortening. Life. https:\/\/doi.org\/10.3390\/life15060873","journal-title":"Life"},{"key":"2661_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010290","author":"K Sawicki","year":"2024","unstructured":"Sawicki K et al (2024) Leukocyte telomere length as a marker of chronic complications in type 2 diabetes patients: a risk assessment study. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26010290","journal-title":"Int J Mol Sci"},{"key":"2661_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ph14020122","author":"J Drzewoski","year":"2021","unstructured":"Drzewoski J, Hanefeld M (2021) The current and potential therapeutic use of metformin-the good old drug. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph14020122","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"2661_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz M, Guigas B, Viollet B (2019) Understanding the glucoregulatory mechanisms of Metformin in type 2 diabetes mellitus. Nat Rev Endocrinol 15(10):569\u2013589","journal-title":"Nat Rev Endocrinol"},{"issue":"51","key":"2661_CR12","doi-asserted-by":"publisher","first-page":"eads5466","DOI":"10.1126\/sciadv.ads5466","volume":"10","author":"CR Reczek","year":"2024","unstructured":"Reczek CR et al (2024) Metformin targets mitochondrial complex I to lower blood glucose levels. Sci Adv 10(51):eads5466","journal-title":"Sci Adv"},{"issue":"1","key":"2661_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.diabres.2010.11.030","volume":"93","author":"A Chakraborty","year":"2011","unstructured":"Chakraborty A, Chowdhury S, Bhattacharyya M (2011) Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Res Clin Pract 93(1):56\u201362","journal-title":"Diabetes Res Clin Pract"},{"key":"2661_CR14","doi-asserted-by":"publisher","first-page":"1330797","DOI":"10.3389\/fphar.2024.1330797","volume":"15","author":"A Buczy\u0144ska","year":"2024","unstructured":"Buczy\u0144ska A et al (2024) Examining the clinical relevance of Metformin as an antioxidant intervention. Front Pharmacol 15:1330797","journal-title":"Front Pharmacol"},{"issue":"3","key":"2661_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11684-023-0998-6","volume":"17","author":"Y Dong","year":"2023","unstructured":"Dong Y et al (2023) The development and benefits of Metformin in various diseases. Front Med 17(3):388\u2013431","journal-title":"Front Med"},{"key":"2661_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv Z, Guo Y (2020) Metformin and its benefits for various diseases. Front Endocrinol (Lausanne) 11:191","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2661_CR17","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.2147\/DMSO.S428560","volume":"16","author":"B Qin","year":"2023","unstructured":"Qin B (2023) Can antidiabetic medications affect telomere length in patients with type 2 diabetes? A mini-review. Diabetes Metab Syndr Obes 16:3739\u20133750","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"2661_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.14336\/AD.2020.0702","volume":"12","author":"D Hu","year":"2021","unstructured":"Hu D et al (2021) Metformin: A potential candidate for targeting aging mechanisms. Aging Dis 12(2):480\u2013493","journal-title":"Aging Dis"},{"issue":"1","key":"2661_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni AS, Gubbi S, Barzilai N (2020) Benefits of metformin in attenuating the hallmarks of aging. Cell Metab 32(1):15\u201330","journal-title":"Cell Metab"},{"issue":"9","key":"2661_CR20","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1038\/s12276-024-01297-w","volume":"56","author":"JY Sung","year":"2024","unstructured":"Sung JY et al (2024) Telomere stabilization by Metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1\u03b1 pathway. Exp Mol Med 56(9):1967\u20131979","journal-title":"Exp Mol Med"},{"issue":"40","key":"2661_CR21","doi-asserted-by":"publisher","first-page":"14398","DOI":"10.1073\/pnas.0504161102","volume":"102","author":"JC Wang","year":"2005","unstructured":"Wang JC et al (2005) Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells. Proc Natl Acad Sci U S A 102(40):14398\u201314403","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2661_CR22","unstructured":"Au-Jain M, Au-Madeka S, Au-Khattar E. JoVE 2023(194):e65288"},{"key":"2661_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.exger.2013.12.004","volume":"51","author":"M Gardner","year":"2014","unstructured":"Gardner M et al (2014) Gender and telomere length: systematic review and meta-analysis. Exp Gerontol 51:15\u201327","journal-title":"Exp Gerontol"},{"issue":"6","key":"2661_CR24","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.celrep.2013.05.030","volume":"3","author":"P Mart\u00ednez","year":"2013","unstructured":"Mart\u00ednez P et al (2013) RAP1 protects from obesity through its extratelomeric role regulating gene expression. Cell Rep 3(6):2059\u20132074","journal-title":"Cell Rep"},{"issue":"5","key":"2661_CR25","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1093\/nar\/gkv097","volume":"43","author":"E Janou\u0161kov\u00e1","year":"2015","unstructured":"Janou\u0161kov\u00e1 E et al (2015) Human Rap1 modulates TRF2 attraction to telomeric DNA. Nucleic Acids Res 43(5):2691\u20132700","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2661_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2007.03.023","volume":"26","author":"NS Bae","year":"2007","unstructured":"Bae NS, Baumann P (2007) A RAP1\/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol Cell 26(3):323\u2013334","journal-title":"Mol Cell"},{"key":"2661_CR27","doi-asserted-by":"publisher","first-page":"581799","DOI":"10.3389\/fimmu.2021.581799","volume":"12","author":"J Hartwig","year":"2021","unstructured":"Hartwig J et al (2021) Metformin Attenuates ROS Front Immunol 12:581799","journal-title":"Metformin Attenuates ROS Front Immunol"},{"issue":"2","key":"2661_CR28","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s40200-021-00835-x","volume":"20","author":"TM Al-Thuwaini","year":"2021","unstructured":"Al-Thuwaini TM (2021) Association of antidiabetic therapy with shortened telomere length in middle-aged type 2 diabetic patients. J Diabetes Metab Disord 20(2):1161\u20131168","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"2661_CR29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.14336\/AD.2021.1213","volume":"13","author":"FF Cheng","year":"2022","unstructured":"Cheng FF et al (2022) Metformin\u2019s mechanisms in attenuating hallmarks of aging and Age-Related disease. Aging Dis 13(4):970\u2013986","journal-title":"Aging Dis"},{"key":"2661_CR30","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/ncomms3192","volume":"4","author":"A Martin-Montalvo","year":"2013","unstructured":"Martin-Montalvo A et al (2013) Metformin improves healthspan and lifespan in mice. Nat Commun 4:2192","journal-title":"Nat Commun"},{"issue":"Suppl 3","key":"2661_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/dom.16422","volume":"27","author":"S Saadati","year":"2025","unstructured":"Saadati S et al (2025) Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges. Diabetes Obes Metab 27(Suppl 3):31\u201347","journal-title":"Diabetes Obes Metab"},{"key":"2661_CR32","doi-asserted-by":"crossref","unstructured":"Ling J et al (2025) Combined liraglutide and Metformin therapy in overweight or obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Diabetes Obes Metab","DOI":"10.1111\/dom.70028"},{"key":"2661_CR33","doi-asserted-by":"publisher","first-page":"1567255","DOI":"10.3389\/fmed.2025.1567255","volume":"12","author":"K Hofmann","year":"2025","unstructured":"Hofmann K et al (2025) Fetuin-B as a biomarker for Metformin response in women with polycystic ovary syndrome: a prospective study. Front Med (Lausanne) 12:1567255","journal-title":"Front Med (Lausanne)"},{"issue":"19","key":"2661_CR34","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1080\/15384101.2017.1371886","volume":"16","author":"Y Cai","year":"2017","unstructured":"Cai Y et al (2017) Decoding telomere protein Rap1: its telomeric and nontelomeric functions and potential implications in diabetic cardiomyopathy. Cell Cycle 16(19):1765\u20131773","journal-title":"Cell Cycle"},{"issue":"8069","key":"2661_CR35","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41586-025-08896-1","volume":"642","author":"P Eickhoff","year":"2025","unstructured":"Eickhoff P et al (2025) Chromosome end protection by RAP1-mediated Inhibition of DNA-PK. Nature 642(8069):1090\u20131096","journal-title":"Nature"},{"issue":"8","key":"2661_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ncb2081","volume":"12","author":"P Martinez","year":"2010","unstructured":"Martinez P et al (2010) Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat Cell Biol 12(8):768\u2013780","journal-title":"Nat Cell Biol"},{"issue":"11","key":"2661_CR37","doi-asserted-by":"publisher","first-page":"e1010506","DOI":"10.1371\/journal.pgen.1010506","volume":"18","author":"AJ Stock","year":"2022","unstructured":"Stock AJ et al (2022) Aberrant expression and localization of the RAP1 shelterin protein contribute to age-related phenotypes. PLoS Genet 18(11):e1010506","journal-title":"PLoS Genet"},{"issue":"5","key":"2661_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0092-8674(00)80858-2","volume":"101","author":"B Li","year":"2000","unstructured":"Li B, Oestreich S, de Lange T (2000) Identification of human Rap1: implications for telomere evolution. Cell 101(5):471\u2013483","journal-title":"Cell"},{"issue":"1","key":"2661_CR39","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1038\/s41598-019-41839-1","volume":"9","author":"ZE Gillespie","year":"2019","unstructured":"Gillespie ZE et al (2019) Metformin induces the AP-1 transcription factor network in normal dermal fibroblasts. Sci Rep 9(1):5369","journal-title":"Sci Rep"},{"issue":"6","key":"2661_CR40","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1152\/japplphysiol.00255.2006","volume":"101","author":"M Suwa","year":"2006","unstructured":"Suwa M et al (2006) Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J Appl Physiol (1985) 101(6):1685\u20131692","journal-title":"J Appl Physiol (1985)"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02661-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T01:40:01Z","timestamp":1776649201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02661-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["2661"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02661-0","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The work was approved from Nanavati Hospital Ethics Committee with the approval number BNH\/1583\/2021 dated 15\/12\/2021.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}